MedPath

Regina Elena Cancer Institute

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

87

Active:7
Completed:18

Trial Phases

4 Phases

Phase 2:7
Phase 3:2
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (36 trials with phase data)• Click on a phase to view related trials

Not Applicable
26 (72.2%)
Phase 2
7 (19.4%)
Phase 3
2 (5.6%)
Phase 4
1 (2.8%)

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

Recruiting
Conditions
Renal Cell Carcinoma
First Posted Date
2025-06-12
Last Posted Date
2025-06-12
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
20
Registration Number
NCT07018037
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases

Not Applicable
Recruiting
Conditions
Brain Metastases
First Posted Date
2025-05-28
Last Posted Date
2025-05-28
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
98
Registration Number
NCT06992973
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

Recruiting
Conditions
Bladder Cancer
First Posted Date
2025-05-28
Last Posted Date
2025-05-28
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
50
Registration Number
NCT06992986
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation

Recruiting
Conditions
Prostatic Neoplasms
First Posted Date
2025-03-25
Last Posted Date
2025-03-25
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
103
Registration Number
NCT06894628
Locations
🇮🇹

IRCSS Regina Elena, Roma, Italy

Feasibility of Day-surgery Management for Patients Undergoing Robotic Radical Prostatectomy: a Randomized Trial

Not Applicable
Active, not recruiting
Conditions
Prostate Cancer
First Posted Date
2025-03-24
Last Posted Date
2025-03-24
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
90
Registration Number
NCT06891664
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.